project id: TCGA-UCEC; case submitter id: TCGA-KP-A3W3; source center: 23; state: released; a260 a280 ratio: 1.83; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.0; rna integrity number: 7.6; age at index: 72; days to birth: -26310; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1938; age at diagnosis: 26310; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 794.0; figo stage: Stage IB; icd 10 code: C54.1; last known disease status: not reported; morphology: 8441/3; primary diagnosis: Serous cystadenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 739; initial weight: 680.0; sample id: d54f4476-7191-4a52-a310-8392f62404cb; sample submitter id: TCGA-KP-A3W3-01A; portion id: 5a71f937-2d46-4083-99f1-1441ca54e010; portion submitter id: TCGA-KP-A3W3-01A-11; slide id: d8ebc5eb-9f64-4146-bce2-018338e5c447; slide submitter id: TCGA-KP-A3W3-01A-01-TS1; percent lymphocyte infiltration: 60.0; percent monocyte infiltration: 20.0; percent necrosis: 5.0; percent neutrophil infiltration: 10.0; percent normal cells: 0.0; percent stromal cells: 5.0; percent tumor cells: 90.0; percent tumor nuclei: 90.0; section location: TOP;